2022
DOI: 10.1016/j.arr.2021.101497
|View full text |Cite
|
Sign up to set email alerts
|

Identification of altered exosomal microRNAs and mRNAs in Alzheimer's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
23
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(28 citation statements)
references
References 58 publications
2
23
0
Order By: Relevance
“…Hence, exosomes participate in various pathological processes, cardiovascular disease, regeneration disease and cancer, for example. 18 , 19 , 20 Recent studies have demonstrated that exosome‐derived circRNAs have a key role in disease progression, which could be the potential candidate for disease therapy. 21 However, little research has focused on the specific function of exosome‐derived circRNAs in PCa.…”
Section: Introductionmentioning
confidence: 99%
“…Hence, exosomes participate in various pathological processes, cardiovascular disease, regeneration disease and cancer, for example. 18 , 19 , 20 Recent studies have demonstrated that exosome‐derived circRNAs have a key role in disease progression, which could be the potential candidate for disease therapy. 21 However, little research has focused on the specific function of exosome‐derived circRNAs in PCa.…”
Section: Introductionmentioning
confidence: 99%
“…Alzheimer’s disease (AD) is a neurodegenerative disease characterized by cognitive and functional impairment, in which age and genetic predisposition are two of the most important risk factors for its development [ 1 ]. One of the pathological features is the formation of extracellular beta-amyloid (Aβ) plaques and intracellular neurofibrillary tangles in the brains of AD patients [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Alzheimer’s disease (AD) is the most common form of dementia characterized by neurodegeneration and memory loss ( Belfiore et al, 2019 ). At the present time, more than 47 million people are suffering from AD across the world; this number is expected to rise to 131 million by 2050 ( Su et al, 2022 ). As the global society ages, AD has become a serious threat to humanity ( Serneels et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%